CHK-263

N/A

Report date: 2023/05/12 16:07:31
NME

Base Information

Drug NameCHK-263
Drug Alias NameCHK-263
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus attachment inhibitorsViral fusion proteins inhibitors
TargetsViral fusion proteins
Therapy Area/IndicationsChikungunya Fever
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesWashington University School Of Medicine
China Registration ClassN/A

Develop Information

Active CompaniesWashington University School Of Medicine
Inactive CompaniesN/A
Active IndicationsChikungunya Fever
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A